CTT Pharmaceutical Pink Sheet Forward View - Double Exponential Smoothing
| CTTH Stock | USD 0.08 0.0001 0.13% |
For short-term price forecasting, CTT Pharmaceutical's sentiment profile - captured through news flow and social engagement - can be as informative as any financial ratio. This module quantifies and translates that data into a price signal.
According to momentum metrics, CTT Pharmaceutical reflects the momentum strength indicator of 0, indicating compressed downside momentum. At these depths, CTT Pharmaceutical may be approaching exhaustion on the sell side, though timing a reversal requires additional confirmation.Momentum
Sell Peaked
Oversold | Overbought |
This section frames CTT Pharmaceutical Holdings response to recent headlines in a peer context.
The Double Exponential Smoothing forecasted value of CTT Pharmaceutical Holdings on the next trading day is projected to be 0.08 with a mean absolute deviation of 0.0046 and the sum of the absolute errors of 0.27.CTT Pharmaceutical after-hype prediction price | $ 0.08 |
This view helps relate attention signals to forecasting and technical indicators plus earnings context.
CTT |
CTT Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine CTT price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CTT using various technical indicators. When you analyze CTT charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Double Exponential Smoothing Price Forecast For the 15th of March 2026
Given 90 days horizon, the Double Exponential Smoothing forecasted value of CTT Pharmaceutical Holdings on the next trading day is expected to be 0.08 with a mean absolute deviation of 0.0046 , mean absolute percentage error of 0.000041 , and the sum of the absolute errors of 0.27 .Please note that although there have been many attempts to predict CTT Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that CTT Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Pink Sheet Forecast Pattern
| Backtest CTT Pharmaceutical | CTT Pharmaceutical Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for CTT Pharmaceutical Holdings uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of CTT Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent CTT Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0012 |
| MAD | Mean absolute deviation | 0.0046 |
| MAPE | Mean absolute percentage error | 0.0656 |
| SAE | Sum of the absolute errors | 0.2718 |
The degree to which CTT Pharmaceutical's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
After-Hype Price Density Analysis
The after-hype price distribution for CTT Pharmaceutical helps investors understand how much of CTT Pharmaceutical's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for CTT Pharmaceutical are inherently more speculative.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical news patterns for CTT Pharmaceutical reveal how the market has historically digested different types of information about CTT Pharmaceutical's business and market environment. CTT Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 9.74, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
The after-hype framework applied to CTT Pharmaceutical Holdings assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CTT Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CTT Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CTT Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.98 | 9.66 | 0.00 | 0.00 | 0 Events | 1 Events | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.08 | 0.08 | 2.56 |
|
Hype Timeline
CTT Pharmaceutical is currently traded for 0.08. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CTT is anticipated to increase in value after the next headline, with the price projected to jump to 0.08 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 2.56%, whereas the daily expected return is currently at 0.98%. The volatility of related hype on CTT Pharmaceutical is about 241500.0%, with the expected price after the next announcement by competition of 0.08. CTT Pharmaceutical Holdings currently holds $87.62 K in liabilities with Debt to Equity (D/E) ratio of 0.12, which may suggest CTT Pharmaceutical is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Historical Fundamental Analysis of CTT Pharmaceutical provides a cross-check on projections for CTT Pharmaceutical. The analysis adds historical context for the projection set.Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of CTT Pharmaceutical's competitive environment by quantifying the market's sensitivity to news across all major players in CTT Pharmaceutical's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BMCS | Biotech Medics Ne | 0.00 | 0 per month | 0.00 | -0.14 | 1.27 | -3.80 | 93.73 | |
| BINP | Bionoid Pharma | 0.00 | 0 per month | 14.22 | 0.13 | 35.00 | -36.36 | 176.17 | |
| PCYN | Procyon | 0.00 | 0 per month | 0.00 | 0.15 | 0.00 | 0.00 | 46.15 | |
| BMMJ | Body And Mind | 0.00 | 0 per month | 19.48 | 0.06 | 48.57 | -32.31 | 121.50 | |
| EDXC | Endexx Corp | 0.02 | 3 per month | 0.00 | -0.13 | 15.38 | -30.00 | 133.33 | |
| MJNA | Medical Marijuana I | 0.00 | 0 per month | 20.20 | 0.17 | 100.00 | -50.00 | 166.67 | |
| GXXY | Galexxy Holdings | 0.00 | 0 per month | 7.88 | 0.05 | 4.88 | -13.95 | 123.48 | |
| SRUTF | Sproutly Canada | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OVATF | Ovation Science | 0.02 | 3 per month | 0.00 | -0.11 | 0.00 | 0.00 | 28.14 | |
| HBRM | Herborium Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for CTT Pharmaceutical
The price trajectory of CTT is the primary concern for any investor assessing it as an opportunity. CTT Pink Sheet price charts are filled with noise that can easily mislead uninformed investment decisions.CTT Pharmaceutical Related Equities
The following equities are related to CTT Pharmaceutical within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing CTT Pharmaceutical against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
CTT Pharmaceutical Market Strength Events
Understanding the market strength of CTT Pharmaceutical pink sheet enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in CTT Pharmaceutical Holdings with greater precision.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.078 | |||
| Day Typical Price | 0.078 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 1.0E-4 |
CTT Pharmaceutical Risk Indicators
Reviewing CTT Pharmaceutical's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding CTT Pharmaceutical's and informs decisions about hedging and position.
| Mean Deviation | 6.19 | |||
| Semi Deviation | 6.15 | |||
| Standard Deviation | 9.88 | |||
| Variance | 97.52 | |||
| Downside Variance | 72.34 | |||
| Semi Variance | 37.77 | |||
| Expected Short fall | -8.78 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for CTT Pharmaceutical
Coverage intensity for CTT Pharmaceutical Holdings matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
More Resources for CTT Pink Sheet Analysis
Other Information on Investing in CTT Pink Sheet
CTT Pharmaceutical financial ratios provide valuation context across profits, cash flow, and enterprise value. They help compare CTT across valuation measures in a consistent way.